SG Americas Securities LLC Has $194,000 Stock Holdings in Fresenius Medical Care AG (NYSE:FMS)

SG Americas Securities LLC cut its holdings in Fresenius Medical Care AG (NYSE:FMS) by 33.3% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 10,150 shares of the company’s stock after selling 5,078 shares during the quarter. SG Americas Securities LLC’s holdings in Fresenius Medical Care were worth $194,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in FMS. GAMMA Investing LLC acquired a new stake in Fresenius Medical Care in the fourth quarter worth about $67,000. VisionPoint Advisory Group LLC bought a new stake in Fresenius Medical Care during the 4th quarter worth about $812,000. QRG Capital Management Inc. raised its holdings in Fresenius Medical Care by 44.9% during the 4th quarter. QRG Capital Management Inc. now owns 45,493 shares of the company’s stock worth $948,000 after purchasing an additional 14,100 shares during the last quarter. Partnership Wealth Management LLC bought a new stake in Fresenius Medical Care during the 4th quarter worth about $2,340,000. Finally, Moran Wealth Management LLC bought a new stake in Fresenius Medical Care during the 4th quarter worth about $3,247,000. 8.25% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several analysts have weighed in on FMS shares. Truist Financial dropped their price objective on Fresenius Medical Care from $24.00 to $22.00 and set a “hold” rating for the company in a report on Wednesday, July 31st. StockNews.com started coverage on Fresenius Medical Care in a report on Wednesday, July 3rd. They set a “strong-buy” rating for the company. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, one has given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and an average price target of $22.00.

Fresenius Medical Care Price Performance

Fresenius Medical Care stock opened at $19.45 on Friday. The firm has a market capitalization of $11.41 billion, a P/E ratio of 21.85, a PEG ratio of 1.01 and a beta of 0.90. Fresenius Medical Care AG has a 1 year low of $16.37 and a 1 year high of $24.48. The business has a 50-day moving average of $19.31 and a 200-day moving average of $19.91. The company has a current ratio of 1.46, a quick ratio of 1.14 and a debt-to-equity ratio of 0.45.

Fresenius Medical Care (NYSE:FMS) last posted its earnings results on Tuesday, July 30th. The company reported $0.38 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.38. The company had revenue of $5.13 billion during the quarter, compared to analyst estimates of $5.28 billion. Fresenius Medical Care had a return on equity of 5.48% and a net margin of 2.72%. On average, equities analysts anticipate that Fresenius Medical Care AG will post 1.5 EPS for the current year.

About Fresenius Medical Care

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.